Sens. Inhofe, Crapo, Colleagues Send Letter to HHS, CMS: Unprecedented Drug Price Control Scheme Threatens Innovation, Future Drug Costs
September 15, 2022
September 15, 2022
WASHINGTON, Sept. 15 -- Sen. James M. Inhofe, R-Oklahoma, issued the following news release and letter:
U.S. Sen. Jim Inhofe (R-Okla.) joined his fellow Senate Republicans, led by U.S. Senate Finance Committee Ranking Member Mike Crapo (R-Idaho), in expressing concerns with the establishment of a permanent government price-setting program, funded by billions of taxpayer dollars, in the partisan Inflation Reduction Act, and raising questions regarding federal health agencies' pl . . .
U.S. Sen. Jim Inhofe (R-Okla.) joined his fellow Senate Republicans, led by U.S. Senate Finance Committee Ranking Member Mike Crapo (R-Idaho), in expressing concerns with the establishment of a permanent government price-setting program, funded by billions of taxpayer dollars, in the partisan Inflation Reduction Act, and raising questions regarding federal health agencies' pl . . .